nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—obesity—hypertension	0.302	1	CtDrD
Phenylpropanolamine—SLC6A2—hypertension	0.0576	0.276	CbGaD
Phenylpropanolamine—Levonordefrin—Methyldopa—hypertension	0.0512	0.434	CrCrCtD
Phenylpropanolamine—ADRA1A—hypertension	0.0406	0.194	CbGaD
Phenylpropanolamine—Isoxsuprine—Labetalol—hypertension	0.0394	0.335	CrCrCtD
Phenylpropanolamine—SLC6A3—hypertension	0.0293	0.14	CbGaD
Phenylpropanolamine—ADRA2A—hypertension	0.0287	0.137	CbGaD
Phenylpropanolamine—ADRB1—hypertension	0.0287	0.137	CbGaD
Phenylpropanolamine—Isoxsuprine—Propranolol—hypertension	0.0272	0.231	CrCrCtD
Phenylpropanolamine—ADRB2—hypertension	0.0241	0.115	CbGaD
Phenylpropanolamine—SLC6A2—Guanadrel—hypertension	0.0116	0.045	CbGbCtD
Phenylpropanolamine—ADRB2—Esmolol—hypertension	0.0105	0.0407	CbGbCtD
Phenylpropanolamine—ADRB1—Esmolol—hypertension	0.0103	0.0401	CbGbCtD
Phenylpropanolamine—SLC6A2—Guanethidine—hypertension	0.00876	0.0341	CbGbCtD
Phenylpropanolamine—ADRB2—Labetalol—hypertension	0.00794	0.0309	CbGbCtD
Phenylpropanolamine—ADRB2—Nadolol—hypertension	0.00794	0.0309	CbGbCtD
Phenylpropanolamine—ADRB2—Nebivolol—hypertension	0.00794	0.0309	CbGbCtD
Phenylpropanolamine—ADRB1—Labetalol—hypertension	0.00782	0.0304	CbGbCtD
Phenylpropanolamine—ADRB1—Nebivolol—hypertension	0.00782	0.0304	CbGbCtD
Phenylpropanolamine—ADRB1—Nadolol—hypertension	0.00782	0.0304	CbGbCtD
Phenylpropanolamine—ADRB2—Acebutolol—hypertension	0.00726	0.0282	CbGbCtD
Phenylpropanolamine—ADRB1—Acebutolol—hypertension	0.00715	0.0278	CbGbCtD
Phenylpropanolamine—ADRB2—Metoprolol—hypertension	0.00675	0.0263	CbGbCtD
Phenylpropanolamine—ADRB2—Pindolol—hypertension	0.00675	0.0263	CbGbCtD
Phenylpropanolamine—ADRB1—Metoprolol—hypertension	0.00665	0.0259	CbGbCtD
Phenylpropanolamine—ADRB1—Pindolol—hypertension	0.00665	0.0259	CbGbCtD
Phenylpropanolamine—DRD1—Fenoldopam—hypertension	0.00656	0.0255	CbGbCtD
Phenylpropanolamine—ADRB2—Betaxolol—hypertension	0.00601	0.0234	CbGbCtD
Phenylpropanolamine—ADRA2A—Methyldopa—hypertension	0.00598	0.0233	CbGbCtD
Phenylpropanolamine—ADRB1—Betaxolol—hypertension	0.00592	0.0231	CbGbCtD
Phenylpropanolamine—ADRB2—Penbutolol—hypertension	0.0055	0.0214	CbGbCtD
Phenylpropanolamine—ADRA2A—Guanabenz—hypertension	0.00547	0.0213	CbGbCtD
Phenylpropanolamine—ADRB1—Penbutolol—hypertension	0.00542	0.0211	CbGbCtD
Phenylpropanolamine—ADRA2A—Guanfacine—hypertension	0.00509	0.0198	CbGbCtD
Phenylpropanolamine—ADRA1A—Terazosin—hypertension	0.00459	0.0178	CbGbCtD
Phenylpropanolamine—ADRA2A—Fenoldopam—hypertension	0.00433	0.0168	CbGbCtD
Phenylpropanolamine—ADRA1A—Fenoldopam—hypertension	0.00415	0.0161	CbGbCtD
Phenylpropanolamine—ADRA2A—Doxazosin—hypertension	0.00399	0.0155	CbGbCtD
Phenylpropanolamine—ADRB2—Timolol—hypertension	0.00388	0.0151	CbGbCtD
Phenylpropanolamine—ADRA1A—Doxazosin—hypertension	0.00383	0.0149	CbGbCtD
Phenylpropanolamine—ADRB1—Timolol—hypertension	0.00382	0.0149	CbGbCtD
Phenylpropanolamine—ADRB2—Carvedilol—hypertension	0.00375	0.0146	CbGbCtD
Phenylpropanolamine—ADRB1—Carvedilol—hypertension	0.0037	0.0144	CbGbCtD
Phenylpropanolamine—ADRB2—Propranolol—hypertension	0.00345	0.0134	CbGbCtD
Phenylpropanolamine—ADRB1—Propranolol—hypertension	0.0034	0.0132	CbGbCtD
Phenylpropanolamine—ADRA2A—Prazosin—hypertension	0.00328	0.0128	CbGbCtD
Phenylpropanolamine—ADRA1A—Prazosin—hypertension	0.00314	0.0122	CbGbCtD
Phenylpropanolamine—ADRA2A—Carvedilol—hypertension	0.00283	0.011	CbGbCtD
Phenylpropanolamine—SLC6A2—Clonidine—hypertension	0.00276	0.0107	CbGbCtD
Phenylpropanolamine—ADRA1A—Nicardipine—hypertension	0.00271	0.0106	CbGbCtD
Phenylpropanolamine—ADRA1A—Carvedilol—hypertension	0.00271	0.0106	CbGbCtD
Phenylpropanolamine—ADRA2A—Clonidine—hypertension	0.00249	0.00967	CbGbCtD
Phenylpropanolamine—ADRA1A—Clonidine—hypertension	0.00238	0.00927	CbGbCtD
Phenylpropanolamine—CYP1A2—Triamterene—hypertension	0.00221	0.0086	CbGbCtD
Phenylpropanolamine—CYP1A2—Guanabenz—hypertension	0.00221	0.0086	CbGbCtD
Phenylpropanolamine—CYP1A2—Betaxolol—hypertension	0.00183	0.00712	CbGbCtD
Phenylpropanolamine—CYP1A2—Nisoldipine—hypertension	0.00161	0.00627	CbGbCtD
Phenylpropanolamine—SLC6A2—locus ceruleus—hypertension	0.00136	0.123	CbGeAlD
Phenylpropanolamine—CYP1A2—Irbesartan—hypertension	0.00127	0.00494	CbGbCtD
Phenylpropanolamine—MAOA—locus ceruleus—hypertension	0.00125	0.113	CbGeAlD
Phenylpropanolamine—CYP1A2—Amlodipine—hypertension	0.00124	0.00484	CbGbCtD
Phenylpropanolamine—CYP1A2—Nifedipine—hypertension	0.00116	0.00452	CbGbCtD
Phenylpropanolamine—CYP1A2—Carvedilol—hypertension	0.00114	0.00445	CbGbCtD
Phenylpropanolamine—SLC6A2—sympathetic nervous system—hypertension	0.00107	0.097	CbGeAlD
Phenylpropanolamine—CYP1A2—Propranolol—hypertension	0.00105	0.00409	CbGbCtD
Phenylpropanolamine—CYP1A2—Clonidine—hypertension	0.001	0.0039	CbGbCtD
Phenylpropanolamine—CYP1A2—Losartan—hypertension	0.000818	0.00318	CbGbCtD
Phenylpropanolamine—SLC6A2—autonomic nervous system—hypertension	0.000722	0.0652	CbGeAlD
Phenylpropanolamine—CYP1A2—Verapamil—hypertension	0.000722	0.00281	CbGbCtD
Phenylpropanolamine—ADRB2—Treprostinil—Nadolol—hypertension	0.000465	1	CbGdCrCtD
Phenylpropanolamine—CYP1A2—urine—hypertension	0.000452	0.0409	CbGeAlD
Phenylpropanolamine—ADRB1—cardiac ventricle—hypertension	0.00027	0.0244	CbGeAlD
Phenylpropanolamine—DRD1—brainstem—hypertension	0.000269	0.0243	CbGeAlD
Phenylpropanolamine—ADRB1—myocardium—hypertension	0.000254	0.0229	CbGeAlD
Phenylpropanolamine—SLC6A3—brainstem—hypertension	0.000216	0.0195	CbGeAlD
Phenylpropanolamine—MAOA—cardiac ventricle—hypertension	0.000212	0.0191	CbGeAlD
Phenylpropanolamine—MAOA—myocardium—hypertension	0.000199	0.018	CbGeAlD
Phenylpropanolamine—ADRB1—heart—hypertension	0.000177	0.016	CbGeAlD
Phenylpropanolamine—SLC6A2—brainstem—hypertension	0.000174	0.0157	CbGeAlD
Phenylpropanolamine—ADRB1—cardiovascular system—hypertension	0.000167	0.0151	CbGeAlD
Phenylpropanolamine—ADRA1A—brainstem—hypertension	0.000162	0.0146	CbGeAlD
Phenylpropanolamine—MAOA—brainstem—hypertension	0.000161	0.0145	CbGeAlD
Phenylpropanolamine—ADRB1—cardiac atrium—hypertension	0.000152	0.0137	CbGeAlD
Phenylpropanolamine—Metaraminol—ADRA1A—hypertension	0.000151	0.0845	CrCbGaD
Phenylpropanolamine—SLC6A2—decidua—hypertension	0.000147	0.0132	CbGeAlD
Phenylpropanolamine—MAOA—nephron tubule—hypertension	0.000146	0.0132	CbGeAlD
Phenylpropanolamine—MAOA—adrenal cortex—hypertension	0.000144	0.013	CbGeAlD
Phenylpropanolamine—ADRA1A—heart—hypertension	0.00014	0.0127	CbGeAlD
Phenylpropanolamine—MAOA—heart—hypertension	0.000139	0.0125	CbGeAlD
Phenylpropanolamine—DRD1—central nervous system—hypertension	0.000136	0.0122	CbGeAlD
Phenylpropanolamine—MAOA—decidua—hypertension	0.000135	0.0122	CbGeAlD
Phenylpropanolamine—ADRA1A—cardiovascular system—hypertension	0.000132	0.0119	CbGeAlD
Phenylpropanolamine—MAOA—cardiovascular system—hypertension	0.000131	0.0118	CbGeAlD
Phenylpropanolamine—MAOA—kidney—hypertension	0.000128	0.0116	CbGeAlD
Phenylpropanolamine—MAOA—cortex of kidney—hypertension	0.000125	0.0113	CbGeAlD
Phenylpropanolamine—SLC6A2—medulla oblongata—hypertension	0.000122	0.011	CbGeAlD
Phenylpropanolamine—MAOA—cardiac atrium—hypertension	0.000119	0.0107	CbGeAlD
Phenylpropanolamine—ADRB1—endocrine gland—hypertension	0.000115	0.0104	CbGeAlD
Phenylpropanolamine—SLC6A2—adrenal gland—hypertension	0.000113	0.0102	CbGeAlD
Phenylpropanolamine—MAOA—medulla oblongata—hypertension	0.000112	0.0101	CbGeAlD
Phenylpropanolamine—Levonordefrin—ADRA2B—hypertension	0.000111	0.0619	CrCbGaD
Phenylpropanolamine—SLC6A3—central nervous system—hypertension	0.000109	0.00984	CbGeAlD
Phenylpropanolamine—ADRA2A—heart—hypertension	0.000107	0.00962	CbGeAlD
Phenylpropanolamine—ADRA1A—adrenal gland—hypertension	0.000105	0.00945	CbGeAlD
Phenylpropanolamine—MAOA—adrenal gland—hypertension	0.000104	0.00936	CbGeAlD
Phenylpropanolamine—ADRA2A—decidua—hypertension	0.000104	0.00936	CbGeAlD
Phenylpropanolamine—ADRB1—central nervous system—hypertension	0.000103	0.00934	CbGeAlD
Phenylpropanolamine—SLC6A2—endocrine gland—hypertension	9.76e-05	0.00881	CbGeAlD
Phenylpropanolamine—Phenelzine—ABAT—hypertension	9.73e-05	0.0545	CrCbGaD
Phenylpropanolamine—Levonordefrin—SLC6A2—hypertension	9.71e-05	0.0544	CrCbGaD
Phenylpropanolamine—ADRA2A—cortex of kidney—hypertension	9.58e-05	0.00865	CbGeAlD
Phenylpropanolamine—ADRA2A—cardiac atrium—hypertension	9.11e-05	0.00823	CbGeAlD
Phenylpropanolamine—ADRA1A—endocrine gland—hypertension	9.07e-05	0.00819	CbGeAlD
Phenylpropanolamine—MAOA—endocrine gland—hypertension	8.99e-05	0.00812	CbGeAlD
Phenylpropanolamine—SLC6A2—central nervous system—hypertension	8.79e-05	0.00794	CbGeAlD
Phenylpropanolamine—ADRA2A—medulla oblongata—hypertension	8.59e-05	0.00776	CbGeAlD
Phenylpropanolamine—Ephedrine—SLC6A2—hypertension	8.31e-05	0.0465	CrCbGaD
Phenylpropanolamine—ADRA1A—central nervous system—hypertension	8.17e-05	0.00738	CbGeAlD
Phenylpropanolamine—Benzyl alcohol—ALDH2—hypertension	8.11e-05	0.0454	CrCbGaD
Phenylpropanolamine—MAOA—central nervous system—hypertension	8.1e-05	0.00732	CbGeAlD
Phenylpropanolamine—ADRA2A—adrenal gland—hypertension	7.95e-05	0.00718	CbGeAlD
Phenylpropanolamine—CYP1A2—endocrine gland—hypertension	7.5e-05	0.00677	CbGeAlD
Phenylpropanolamine—L-Phenylalanine—TH—hypertension	7.34e-05	0.0411	CrCbGaD
Phenylpropanolamine—ADRA2A—endocrine gland—hypertension	6.9e-05	0.00623	CbGeAlD
Phenylpropanolamine—Levonordefrin—ADRA1A—hypertension	6.84e-05	0.0383	CrCbGaD
Phenylpropanolamine—Phentermine—SLC6A2—hypertension	6.64e-05	0.0372	CrCbGaD
Phenylpropanolamine—Dextroamphetamine—SLC6A2—hypertension	6.34e-05	0.0355	CrCbGaD
Phenylpropanolamine—Pseudoephedrine—SLC6A2—hypertension	6.3e-05	0.0353	CrCbGaD
Phenylpropanolamine—ADRA2A—central nervous system—hypertension	6.22e-05	0.00561	CbGeAlD
Phenylpropanolamine—Ephedrine—ADRA1A—hypertension	5.85e-05	0.0328	CrCbGaD
Phenylpropanolamine—Methamphetamine—ADRA2B—hypertension	5.39e-05	0.0302	CrCbGaD
Phenylpropanolamine—Amphetamine—SLC6A2—hypertension	5.11e-05	0.0286	CrCbGaD
Phenylpropanolamine—Levonordefrin—ADRA2A—hypertension	4.84e-05	0.0271	CrCbGaD
Phenylpropanolamine—Methamphetamine—SLC6A2—hypertension	4.73e-05	0.0265	CrCbGaD
Phenylpropanolamine—Dextroamphetamine—ADRA1A—hypertension	4.46e-05	0.025	CrCbGaD
Phenylpropanolamine—Pseudoephedrine—ADRA1A—hypertension	4.44e-05	0.0248	CrCbGaD
Phenylpropanolamine—Ephedrine—ADRB2—hypertension	3.48e-05	0.0195	CrCbGaD
Phenylpropanolamine—Hypersensitivity—Diltiazem—hypertension	3.4e-05	0.000616	CcSEcCtD
Phenylpropanolamine—Tachycardia—Hydrochlorothiazide—hypertension	3.4e-05	0.000616	CcSEcCtD
Phenylpropanolamine—Hypotension—Captopril—hypertension	3.39e-05	0.000614	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Trandolapril—hypertension	3.39e-05	0.000613	CcSEcCtD
Phenylpropanolamine—Nausea—Eprosartan—hypertension	3.38e-05	0.000613	CcSEcCtD
Phenylpropanolamine—Phentermine—SLC6A3—hypertension	3.38e-05	0.0189	CrCbGaD
Phenylpropanolamine—Somnolence—Trandolapril—hypertension	3.38e-05	0.000612	CcSEcCtD
Phenylpropanolamine—Insomnia—Telmisartan—hypertension	3.38e-05	0.000611	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Enalapril—hypertension	3.37e-05	0.000611	CcSEcCtD
Phenylpropanolamine—Nervousness—Ramipril—hypertension	3.37e-05	0.000611	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Carvedilol—hypertension	3.37e-05	0.00061	CcSEcCtD
Phenylpropanolamine—Somnolence—Enalapril—hypertension	3.36e-05	0.000609	CcSEcCtD
Phenylpropanolamine—Flushing—Lisinopril—hypertension	3.36e-05	0.000608	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Olmesartan—hypertension	3.35e-05	0.000607	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Doxazosin—hypertension	3.33e-05	0.000604	CcSEcCtD
Phenylpropanolamine—Confusional state—Losartan—hypertension	3.33e-05	0.000604	CcSEcCtD
Phenylpropanolamine—Tension—Timolol—hypertension	3.33e-05	0.000603	CcSEcCtD
Phenylpropanolamine—Constipation—Clonidine—hypertension	3.33e-05	0.000603	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Telmisartan—hypertension	3.33e-05	0.000603	CcSEcCtD
Phenylpropanolamine—Somnolence—Telmisartan—hypertension	3.32e-05	0.000601	CcSEcCtD
Phenylpropanolamine—Tachycardia—Betaxolol—hypertension	3.31e-05	0.000599	CcSEcCtD
Phenylpropanolamine—Vomiting—Guanabenz—hypertension	3.3e-05	0.000598	CcSEcCtD
Phenylpropanolamine—Vomiting—Metoprolol—hypertension	3.3e-05	0.000598	CcSEcCtD
Phenylpropanolamine—Nervousness—Timolol—hypertension	3.3e-05	0.000597	CcSEcCtD
Phenylpropanolamine—Hypotension—Perindopril—hypertension	3.29e-05	0.000596	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Fosinopril—hypertension	3.29e-05	0.000596	CcSEcCtD
Phenylpropanolamine—Nausea—Nisoldipine—hypertension	3.29e-05	0.000595	CcSEcCtD
Phenylpropanolamine—Nausea—Amlodipine—hypertension	3.29e-05	0.000595	CcSEcCtD
Phenylpropanolamine—Insomnia—Captopril—hypertension	3.28e-05	0.000594	CcSEcCtD
Phenylpropanolamine—Hypotension—Irbesartan—hypertension	3.28e-05	0.000594	CcSEcCtD
Phenylpropanolamine—Rash—Guanabenz—hypertension	3.28e-05	0.000593	CcSEcCtD
Phenylpropanolamine—Rash—Metoprolol—hypertension	3.28e-05	0.000593	CcSEcCtD
Phenylpropanolamine—Dermatitis—Metoprolol—hypertension	3.27e-05	0.000593	CcSEcCtD
Phenylpropanolamine—Dermatitis—Guanabenz—hypertension	3.27e-05	0.000593	CcSEcCtD
Phenylpropanolamine—Hypotension—Hydrochlorothiazide—hypertension	3.26e-05	0.000589	CcSEcCtD
Phenylpropanolamine—Tremor—Ramipril—hypertension	3.25e-05	0.000589	CcSEcCtD
Phenylpropanolamine—Constipation—Trandolapril—hypertension	3.25e-05	0.000588	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Nifedipine—hypertension	3.25e-05	0.000588	CcSEcCtD
Phenylpropanolamine—Constipation—Enalapril—hypertension	3.24e-05	0.000586	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Captopril—hypertension	3.24e-05	0.000586	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Verapamil—hypertension	3.23e-05	0.000586	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Lisinopril—hypertension	3.23e-05	0.000585	CcSEcCtD
Phenylpropanolamine—Somnolence—Captopril—hypertension	3.23e-05	0.000584	CcSEcCtD
Phenylpropanolamine—Tachycardia—Losartan—hypertension	3.23e-05	0.000584	CcSEcCtD
Phenylpropanolamine—Dextroamphetamine—SLC6A3—hypertension	3.22e-05	0.0181	CrCbGaD
Phenylpropanolamine—Feeling abnormal—Clonidine—hypertension	3.21e-05	0.000581	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—SLC6A3—hypertension	3.2e-05	0.0179	CrCbGaD
Phenylpropanolamine—Hypotension—Furosemide—hypertension	3.2e-05	0.00058	CcSEcCtD
Phenylpropanolamine—Vision blurred—Timolol—hypertension	3.2e-05	0.000579	CcSEcCtD
Phenylpropanolamine—Constipation—Telmisartan—hypertension	3.19e-05	0.000578	CcSEcCtD
Phenylpropanolamine—Agitation—Ramipril—hypertension	3.19e-05	0.000578	CcSEcCtD
Phenylpropanolamine—Insomnia—Perindopril—hypertension	3.19e-05	0.000577	CcSEcCtD
Phenylpropanolamine—Hypotension—Betaxolol—hypertension	3.17e-05	0.000574	CcSEcCtD
Phenylpropanolamine—Dizziness—Propranolol—hypertension	3.16e-05	0.000571	CcSEcCtD
Phenylpropanolamine—Insomnia—Hydrochlorothiazide—hypertension	3.15e-05	0.000571	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Perindopril—hypertension	3.14e-05	0.000569	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—ADRA2A—hypertension	3.14e-05	0.0176	CrCbGaD
Phenylpropanolamine—Pseudoephedrine—ADRB1—hypertension	3.14e-05	0.0176	CrCbGaD
Phenylpropanolamine—Somnolence—Perindopril—hypertension	3.13e-05	0.000567	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Irbesartan—hypertension	3.13e-05	0.000567	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Trandolapril—hypertension	3.13e-05	0.000567	CcSEcCtD
Phenylpropanolamine—Somnolence—Irbesartan—hypertension	3.12e-05	0.000565	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Enalapril—hypertension	3.12e-05	0.000565	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Hydrochlorothiazide—hypertension	3.11e-05	0.000562	CcSEcCtD
Phenylpropanolamine—Constipation—Captopril—hypertension	3.1e-05	0.000562	CcSEcCtD
Phenylpropanolamine—Somnolence—Hydrochlorothiazide—hypertension	3.1e-05	0.000561	CcSEcCtD
Phenylpropanolamine—Tension—Lisinopril—hypertension	3.09e-05	0.00056	CcSEcCtD
Phenylpropanolamine—Hypotension—Losartan—hypertension	3.09e-05	0.000559	CcSEcCtD
Phenylpropanolamine—Nausea—Metoprolol—hypertension	3.09e-05	0.000559	CcSEcCtD
Phenylpropanolamine—Nausea—Guanabenz—hypertension	3.09e-05	0.000559	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Telmisartan—hypertension	3.08e-05	0.000557	CcSEcCtD
Phenylpropanolamine—Insomnia—Betaxolol—hypertension	3.07e-05	0.000556	CcSEcCtD
Phenylpropanolamine—Nervousness—Lisinopril—hypertension	3.06e-05	0.000554	CcSEcCtD
Phenylpropanolamine—Dizziness—Diltiazem—hypertension	3.06e-05	0.000553	CcSEcCtD
Phenylpropanolamine—Dizziness—Indapamide—hypertension	3.06e-05	0.000553	CcSEcCtD
Phenylpropanolamine—Somnolence—Furosemide—hypertension	3.05e-05	0.000552	CcSEcCtD
Phenylpropanolamine—Vomiting—Propranolol—hypertension	3.03e-05	0.000549	CcSEcCtD
Phenylpropanolamine—Dizziness—Carvedilol—hypertension	3.03e-05	0.000548	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Betaxolol—hypertension	3.02e-05	0.000548	CcSEcCtD
Phenylpropanolamine—Constipation—Perindopril—hypertension	3.01e-05	0.000546	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Valsartan—hypertension	3.01e-05	0.000545	CcSEcCtD
Phenylpropanolamine—Rash—Propranolol—hypertension	3.01e-05	0.000545	CcSEcCtD
Phenylpropanolamine—Dermatitis—Propranolol—hypertension	3.01e-05	0.000544	CcSEcCtD
Phenylpropanolamine—Constipation—Irbesartan—hypertension	3e-05	0.000544	CcSEcCtD
Phenylpropanolamine—Dizziness—Doxazosin—hypertension	2.99e-05	0.000542	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Captopril—hypertension	2.99e-05	0.000542	CcSEcCtD
Phenylpropanolamine—Insomnia—Losartan—hypertension	2.99e-05	0.000541	CcSEcCtD
Phenylpropanolamine—Constipation—Hydrochlorothiazide—hypertension	2.98e-05	0.000539	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—TNF—hypertension	2.98e-05	0.0167	CrCbGaD
Phenylpropanolamine—Vision blurred—Lisinopril—hypertension	2.97e-05	0.000538	CcSEcCtD
Phenylpropanolamine—Dizziness—Fosinopril—hypertension	2.96e-05	0.000535	CcSEcCtD
Phenylpropanolamine—Tremor—Lisinopril—hypertension	2.95e-05	0.000534	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Losartan—hypertension	2.95e-05	0.000534	CcSEcCtD
Phenylpropanolamine—Anxiety—Ramipril—hypertension	2.95e-05	0.000534	CcSEcCtD
Phenylpropanolamine—Somnolence—Losartan—hypertension	2.94e-05	0.000532	CcSEcCtD
Phenylpropanolamine—Dizziness—Eplerenone—hypertension	2.94e-05	0.000532	CcSEcCtD
Phenylpropanolamine—Vomiting—Indapamide—hypertension	2.94e-05	0.000532	CcSEcCtD
Phenylpropanolamine—Vomiting—Diltiazem—hypertension	2.94e-05	0.000532	CcSEcCtD
Phenylpropanolamine—Constipation—Furosemide—hypertension	2.93e-05	0.000531	CcSEcCtD
Phenylpropanolamine—Dizziness—Nifedipine—hypertension	2.92e-05	0.000528	CcSEcCtD
Phenylpropanolamine—Rash—Diltiazem—hypertension	2.91e-05	0.000527	CcSEcCtD
Phenylpropanolamine—Rash—Indapamide—hypertension	2.91e-05	0.000527	CcSEcCtD
Phenylpropanolamine—Dermatitis—Indapamide—hypertension	2.91e-05	0.000527	CcSEcCtD
Phenylpropanolamine—Dermatitis—Diltiazem—hypertension	2.91e-05	0.000527	CcSEcCtD
Phenylpropanolamine—Vomiting—Carvedilol—hypertension	2.91e-05	0.000527	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Perindopril—hypertension	2.9e-05	0.000526	CcSEcCtD
Phenylpropanolamine—Dizziness—Verapamil—hypertension	2.9e-05	0.000526	CcSEcCtD
Phenylpropanolamine—Constipation—Betaxolol—hypertension	2.9e-05	0.000525	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Irbesartan—hypertension	2.89e-05	0.000524	CcSEcCtD
Phenylpropanolamine—Rash—Carvedilol—hypertension	2.88e-05	0.000522	CcSEcCtD
Phenylpropanolamine—Dermatitis—Carvedilol—hypertension	2.88e-05	0.000522	CcSEcCtD
Phenylpropanolamine—Anxiety—Timolol—hypertension	2.88e-05	0.000522	CcSEcCtD
Phenylpropanolamine—Vomiting—Doxazosin—hypertension	2.88e-05	0.000521	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Hydrochlorothiazide—hypertension	2.87e-05	0.00052	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Clonidine—hypertension	2.87e-05	0.00052	CcSEcCtD
Phenylpropanolamine—Phenelzine—CYP3A5—hypertension	2.87e-05	0.0161	CrCbGaD
Phenylpropanolamine—Confusional state—Ramipril—hypertension	2.86e-05	0.000518	CcSEcCtD
Phenylpropanolamine—Rash—Doxazosin—hypertension	2.85e-05	0.000517	CcSEcCtD
Phenylpropanolamine—Dermatitis—Doxazosin—hypertension	2.85e-05	0.000516	CcSEcCtD
Phenylpropanolamine—Vomiting—Fosinopril—hypertension	2.84e-05	0.000515	CcSEcCtD
Phenylpropanolamine—Nausea—Propranolol—hypertension	2.84e-05	0.000513	CcSEcCtD
Phenylpropanolamine—Constipation—Losartan—hypertension	2.83e-05	0.000512	CcSEcCtD
Phenylpropanolamine—Vomiting—Eplerenone—hypertension	2.82e-05	0.000511	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Furosemide—hypertension	2.82e-05	0.000511	CcSEcCtD
Phenylpropanolamine—Rash—Fosinopril—hypertension	2.82e-05	0.00051	CcSEcCtD
Phenylpropanolamine—Dermatitis—Fosinopril—hypertension	2.82e-05	0.00051	CcSEcCtD
Phenylpropanolamine—Vomiting—Nifedipine—hypertension	2.8e-05	0.000508	CcSEcCtD
Phenylpropanolamine—Rash—Eplerenone—hypertension	2.8e-05	0.000507	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Trandolapril—hypertension	2.8e-05	0.000507	CcSEcCtD
Phenylpropanolamine—Dermatitis—Eplerenone—hypertension	2.8e-05	0.000507	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Betaxolol—hypertension	2.8e-05	0.000506	CcSEcCtD
Phenylpropanolamine—Confusional state—Timolol—hypertension	2.79e-05	0.000506	CcSEcCtD
Phenylpropanolamine—Vomiting—Verapamil—hypertension	2.79e-05	0.000505	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Enalapril—hypertension	2.79e-05	0.000505	CcSEcCtD
Phenylpropanolamine—Rash—Nifedipine—hypertension	2.78e-05	0.000503	CcSEcCtD
Phenylpropanolamine—Dermatitis—Nifedipine—hypertension	2.78e-05	0.000503	CcSEcCtD
Phenylpropanolamine—Rash—Verapamil—hypertension	2.77e-05	0.000501	CcSEcCtD
Phenylpropanolamine—Tachycardia—Ramipril—hypertension	2.77e-05	0.000501	CcSEcCtD
Phenylpropanolamine—Dermatitis—Verapamil—hypertension	2.77e-05	0.000501	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Telmisartan—hypertension	2.75e-05	0.000498	CcSEcCtD
Phenylpropanolamine—Nausea—Indapamide—hypertension	2.74e-05	0.000497	CcSEcCtD
Phenylpropanolamine—Nausea—Diltiazem—hypertension	2.74e-05	0.000497	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Losartan—hypertension	2.72e-05	0.000493	CcSEcCtD
Phenylpropanolamine—Nausea—Carvedilol—hypertension	2.72e-05	0.000492	CcSEcCtD
Phenylpropanolamine—Dizziness—Valsartan—hypertension	2.7e-05	0.000489	CcSEcCtD
Phenylpropanolamine—Dizziness—Olmesartan—hypertension	2.69e-05	0.000487	CcSEcCtD
Phenylpropanolamine—Nausea—Doxazosin—hypertension	2.69e-05	0.000487	CcSEcCtD
Phenylpropanolamine—Anxiety—Lisinopril—hypertension	2.67e-05	0.000484	CcSEcCtD
Phenylpropanolamine—Nausea—Fosinopril—hypertension	2.65e-05	0.000481	CcSEcCtD
Phenylpropanolamine—Hypotension—Ramipril—hypertension	2.65e-05	0.00048	CcSEcCtD
Phenylpropanolamine—Nausea—Eplerenone—hypertension	2.64e-05	0.000478	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—ADRB2—hypertension	2.64e-05	0.0148	CrCbGaD
Phenylpropanolamine—Nausea—Nifedipine—hypertension	2.62e-05	0.000474	CcSEcCtD
Phenylpropanolamine—Nausea—Verapamil—hypertension	2.61e-05	0.000472	CcSEcCtD
Phenylpropanolamine—Vomiting—Valsartan—hypertension	2.6e-05	0.000471	CcSEcCtD
Phenylpropanolamine—Amphetamine—SLC6A3—hypertension	2.6e-05	0.0146	CrCbGaD
Phenylpropanolamine—Confusional state—Lisinopril—hypertension	2.59e-05	0.000469	CcSEcCtD
Phenylpropanolamine—Hypotension—Timolol—hypertension	2.59e-05	0.000469	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Irbesartan—hypertension	2.59e-05	0.000469	CcSEcCtD
Phenylpropanolamine—Vomiting—Olmesartan—hypertension	2.59e-05	0.000468	CcSEcCtD
Phenylpropanolamine—Rash—Valsartan—hypertension	2.58e-05	0.000467	CcSEcCtD
Phenylpropanolamine—Dizziness—Clonidine—hypertension	2.58e-05	0.000467	CcSEcCtD
Phenylpropanolamine—Dermatitis—Valsartan—hypertension	2.58e-05	0.000466	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Hydrochlorothiazide—hypertension	2.57e-05	0.000465	CcSEcCtD
Phenylpropanolamine—Rash—Olmesartan—hypertension	2.57e-05	0.000464	CcSEcCtD
Phenylpropanolamine—Insomnia—Ramipril—hypertension	2.56e-05	0.000464	CcSEcCtD
Phenylpropanolamine—Dermatitis—Olmesartan—hypertension	2.56e-05	0.000464	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Ramipril—hypertension	2.53e-05	0.000458	CcSEcCtD
Phenylpropanolamine—Phentermine—SLC6A4—hypertension	2.53e-05	0.0142	CrCbGaD
Phenylpropanolamine—Hypersensitivity—Furosemide—hypertension	2.52e-05	0.000457	CcSEcCtD
Phenylpropanolamine—Somnolence—Ramipril—hypertension	2.52e-05	0.000456	CcSEcCtD
Phenylpropanolamine—Dizziness—Trandolapril—hypertension	2.51e-05	0.000455	CcSEcCtD
Phenylpropanolamine—Tachycardia—Lisinopril—hypertension	2.51e-05	0.000454	CcSEcCtD
Phenylpropanolamine—Insomnia—Timolol—hypertension	2.51e-05	0.000454	CcSEcCtD
Phenylpropanolamine—Dizziness—Enalapril—hypertension	2.5e-05	0.000453	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Betaxolol—hypertension	2.5e-05	0.000453	CcSEcCtD
Phenylpropanolamine—Vomiting—Clonidine—hypertension	2.48e-05	0.000449	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Timolol—hypertension	2.47e-05	0.000447	CcSEcCtD
Phenylpropanolamine—Dizziness—Telmisartan—hypertension	2.47e-05	0.000447	CcSEcCtD
Phenylpropanolamine—Somnolence—Timolol—hypertension	2.46e-05	0.000446	CcSEcCtD
Phenylpropanolamine—Rash—Clonidine—hypertension	2.46e-05	0.000445	CcSEcCtD
Phenylpropanolamine—Dermatitis—Clonidine—hypertension	2.45e-05	0.000444	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Losartan—hypertension	2.44e-05	0.000441	CcSEcCtD
Phenylpropanolamine—Nausea—Valsartan—hypertension	2.43e-05	0.00044	CcSEcCtD
Phenylpropanolamine—Constipation—Ramipril—hypertension	2.42e-05	0.000439	CcSEcCtD
Phenylpropanolamine—Nausea—Olmesartan—hypertension	2.42e-05	0.000438	CcSEcCtD
Phenylpropanolamine—Vomiting—Trandolapril—hypertension	2.42e-05	0.000437	CcSEcCtD
Phenylpropanolamine—Methamphetamine—SLC6A3—hypertension	2.41e-05	0.0135	CrCbGaD
Phenylpropanolamine—Vomiting—Enalapril—hypertension	2.41e-05	0.000436	CcSEcCtD
Phenylpropanolamine—Hypotension—Lisinopril—hypertension	2.4e-05	0.000435	CcSEcCtD
Phenylpropanolamine—Dizziness—Captopril—hypertension	2.4e-05	0.000435	CcSEcCtD
Phenylpropanolamine—Rash—Trandolapril—hypertension	2.4e-05	0.000434	CcSEcCtD
Phenylpropanolamine—Pseudoephedrine—SLC6A4—hypertension	2.4e-05	0.0134	CrCbGaD
Phenylpropanolamine—Dermatitis—Trandolapril—hypertension	2.39e-05	0.000433	CcSEcCtD
Phenylpropanolamine—Rash—Enalapril—hypertension	2.39e-05	0.000432	CcSEcCtD
Phenylpropanolamine—Dermatitis—Enalapril—hypertension	2.38e-05	0.000432	CcSEcCtD
Phenylpropanolamine—Vomiting—Telmisartan—hypertension	2.37e-05	0.00043	CcSEcCtD
Phenylpropanolamine—Methamphetamine—ADRA2A—hypertension	2.36e-05	0.0132	CrCbGaD
Phenylpropanolamine—Rash—Telmisartan—hypertension	2.35e-05	0.000426	CcSEcCtD
Phenylpropanolamine—Dermatitis—Telmisartan—hypertension	2.35e-05	0.000426	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Ramipril—hypertension	2.34e-05	0.000423	CcSEcCtD
Phenylpropanolamine—Dizziness—Perindopril—hypertension	2.33e-05	0.000422	CcSEcCtD
Phenylpropanolamine—Insomnia—Lisinopril—hypertension	2.33e-05	0.000421	CcSEcCtD
Phenylpropanolamine—Dizziness—Irbesartan—hypertension	2.32e-05	0.000421	CcSEcCtD
Phenylpropanolamine—Nausea—Clonidine—hypertension	2.31e-05	0.000419	CcSEcCtD
Phenylpropanolamine—Vomiting—Captopril—hypertension	2.31e-05	0.000418	CcSEcCtD
Phenylpropanolamine—Dizziness—Hydrochlorothiazide—hypertension	2.3e-05	0.000417	CcSEcCtD
Phenylpropanolamine—Benzyl alcohol—CYP1A1—hypertension	2.3e-05	0.0129	CrCbGaD
Phenylpropanolamine—Dyspnoea—Lisinopril—hypertension	2.29e-05	0.000415	CcSEcCtD
Phenylpropanolamine—Rash—Captopril—hypertension	2.29e-05	0.000414	CcSEcCtD
Phenylpropanolamine—Dermatitis—Captopril—hypertension	2.29e-05	0.000414	CcSEcCtD
Phenylpropanolamine—Somnolence—Lisinopril—hypertension	2.29e-05	0.000414	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Timolol—hypertension	2.28e-05	0.000413	CcSEcCtD
Phenylpropanolamine—Dizziness—Furosemide—hypertension	2.27e-05	0.00041	CcSEcCtD
Phenylpropanolamine—Nausea—Trandolapril—hypertension	2.26e-05	0.000409	CcSEcCtD
Phenylpropanolamine—Nausea—Enalapril—hypertension	2.25e-05	0.000407	CcSEcCtD
Phenylpropanolamine—Dizziness—Betaxolol—hypertension	2.24e-05	0.000406	CcSEcCtD
Phenylpropanolamine—Vomiting—Perindopril—hypertension	2.24e-05	0.000406	CcSEcCtD
Phenylpropanolamine—Vomiting—Irbesartan—hypertension	2.23e-05	0.000404	CcSEcCtD
Phenylpropanolamine—Rash—Perindopril—hypertension	2.22e-05	0.000402	CcSEcCtD
Phenylpropanolamine—Dermatitis—Perindopril—hypertension	2.22e-05	0.000402	CcSEcCtD
Phenylpropanolamine—Nausea—Telmisartan—hypertension	2.22e-05	0.000401	CcSEcCtD
Phenylpropanolamine—Vomiting—Hydrochlorothiazide—hypertension	2.22e-05	0.000401	CcSEcCtD
Phenylpropanolamine—Rash—Irbesartan—hypertension	2.22e-05	0.000401	CcSEcCtD
Phenylpropanolamine—Dermatitis—Irbesartan—hypertension	2.21e-05	0.000401	CcSEcCtD
Phenylpropanolamine—Constipation—Lisinopril—hypertension	2.2e-05	0.000398	CcSEcCtD
Phenylpropanolamine—Rash—Hydrochlorothiazide—hypertension	2.2e-05	0.000398	CcSEcCtD
Phenylpropanolamine—Dermatitis—Hydrochlorothiazide—hypertension	2.19e-05	0.000397	CcSEcCtD
Phenylpropanolamine—Dizziness—Losartan—hypertension	2.19e-05	0.000396	CcSEcCtD
Phenylpropanolamine—Vomiting—Furosemide—hypertension	2.18e-05	0.000394	CcSEcCtD
Phenylpropanolamine—Rash—Furosemide—hypertension	2.16e-05	0.000391	CcSEcCtD
Phenylpropanolamine—Dermatitis—Furosemide—hypertension	2.16e-05	0.000391	CcSEcCtD
Phenylpropanolamine—Vomiting—Betaxolol—hypertension	2.16e-05	0.000391	CcSEcCtD
Phenylpropanolamine—Nausea—Captopril—hypertension	2.16e-05	0.00039	CcSEcCtD
Phenylpropanolamine—Rash—Betaxolol—hypertension	2.14e-05	0.000387	CcSEcCtD
Phenylpropanolamine—Dermatitis—Betaxolol—hypertension	2.14e-05	0.000387	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Lisinopril—hypertension	2.12e-05	0.000384	CcSEcCtD
Phenylpropanolamine—Vomiting—Losartan—hypertension	2.1e-05	0.000381	CcSEcCtD
Phenylpropanolamine—Nausea—Perindopril—hypertension	2.09e-05	0.000379	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Ramipril—hypertension	2.09e-05	0.000378	CcSEcCtD
Phenylpropanolamine—Nausea—Irbesartan—hypertension	2.09e-05	0.000378	CcSEcCtD
Phenylpropanolamine—Rash—Losartan—hypertension	2.08e-05	0.000377	CcSEcCtD
Phenylpropanolamine—Dermatitis—Losartan—hypertension	2.08e-05	0.000377	CcSEcCtD
Phenylpropanolamine—Nausea—Hydrochlorothiazide—hypertension	2.07e-05	0.000375	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Timolol—hypertension	2.04e-05	0.00037	CcSEcCtD
Phenylpropanolamine—Nausea—Furosemide—hypertension	2.04e-05	0.000368	CcSEcCtD
Phenylpropanolamine—Nausea—Betaxolol—hypertension	2.02e-05	0.000365	CcSEcCtD
Phenylpropanolamine—Nausea—Losartan—hypertension	1.96e-05	0.000356	CcSEcCtD
Phenylpropanolamine—Amphetamine—SLC6A4—hypertension	1.94e-05	0.0109	CrCbGaD
Phenylpropanolamine—Amphetamine—DRD2—hypertension	1.93e-05	0.0108	CrCbGaD
Phenylpropanolamine—Hypersensitivity—Lisinopril—hypertension	1.89e-05	0.000343	CcSEcCtD
Phenylpropanolamine—Dizziness—Ramipril—hypertension	1.87e-05	0.000339	CcSEcCtD
Phenylpropanolamine—Dizziness—Timolol—hypertension	1.83e-05	0.000332	CcSEcCtD
Phenylpropanolamine—Vomiting—Ramipril—hypertension	1.8e-05	0.000326	CcSEcCtD
Phenylpropanolamine—Methamphetamine—SLC6A4—hypertension	1.8e-05	0.0101	CrCbGaD
Phenylpropanolamine—Rash—Ramipril—hypertension	1.79e-05	0.000324	CcSEcCtD
Phenylpropanolamine—Dermatitis—Ramipril—hypertension	1.79e-05	0.000323	CcSEcCtD
Phenylpropanolamine—Vomiting—Timolol—hypertension	1.76e-05	0.000319	CcSEcCtD
Phenylpropanolamine—Rash—Timolol—hypertension	1.75e-05	0.000316	CcSEcCtD
Phenylpropanolamine—Dermatitis—Timolol—hypertension	1.75e-05	0.000316	CcSEcCtD
Phenylpropanolamine—Dizziness—Lisinopril—hypertension	1.7e-05	0.000308	CcSEcCtD
Phenylpropanolamine—Nausea—Ramipril—hypertension	1.68e-05	0.000305	CcSEcCtD
Phenylpropanolamine—Nausea—Timolol—hypertension	1.65e-05	0.000298	CcSEcCtD
Phenylpropanolamine—Vomiting—Lisinopril—hypertension	1.63e-05	0.000296	CcSEcCtD
Phenylpropanolamine—Rash—Lisinopril—hypertension	1.62e-05	0.000293	CcSEcCtD
Phenylpropanolamine—Dermatitis—Lisinopril—hypertension	1.62e-05	0.000293	CcSEcCtD
Phenylpropanolamine—Nausea—Lisinopril—hypertension	1.53e-05	0.000276	CcSEcCtD
Phenylpropanolamine—ADRA2A—Metabolism—APOA1—hypertension	8.45e-07	1.86e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ENO1—hypertension	8.44e-07	1.85e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PTGS1—hypertension	8.44e-07	1.85e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ADCY5—hypertension	8.35e-07	1.83e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—SERPINE1—hypertension	8.3e-07	1.82e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hypertension	8.3e-07	1.82e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PRKCG—hypertension	8.3e-07	1.82e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HTR2A—hypertension	8.28e-07	1.82e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—C3—hypertension	8.27e-07	1.81e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ITGB3—hypertension	8.24e-07	1.81e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PRKCA—hypertension	8.24e-07	1.81e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—YWHAZ—hypertension	8.17e-07	1.79e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—POMC—hypertension	8.17e-07	1.79e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—INS—hypertension	8.13e-07	1.78e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CTGF—hypertension	8.13e-07	1.78e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NGF—hypertension	8.08e-07	1.77e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SPP1—hypertension	8.08e-07	1.77e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—HMGCR—hypertension	8.05e-07	1.77e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GOT2—hypertension	8.05e-07	1.77e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PDGFB—hypertension	8.05e-07	1.77e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CXCL8—hypertension	8.05e-07	1.77e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—FGF2—hypertension	8.04e-07	1.76e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—RHOA—hypertension	8.01e-07	1.76e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—FGFR1—hypertension	8.01e-07	1.76e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCL2—hypertension	8e-07	1.76e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—POMC—hypertension	7.99e-07	1.75e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—INS—hypertension	7.95e-07	1.74e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	7.94e-07	1.74e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PIK3R1—hypertension	7.93e-07	1.74e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NOS3—hypertension	7.93e-07	1.74e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HIF1A—hypertension	7.88e-07	1.73e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ADRA2A—hypertension	7.88e-07	1.73e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCR5—hypertension	7.86e-07	1.73e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PRKCD—hypertension	7.86e-07	1.73e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IGF1—hypertension	7.86e-07	1.73e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—AGT—hypertension	7.86e-07	1.72e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—AKT2—hypertension	7.86e-07	1.72e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—EGFR—hypertension	7.82e-07	1.72e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCL2—hypertension	7.82e-07	1.72e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CALM1—hypertension	7.72e-07	1.7e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—APOE—hypertension	7.7e-07	1.69e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—LEP—hypertension	7.7e-07	1.69e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HTR2A—hypertension	7.69e-07	1.69e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IGF1—hypertension	7.69e-07	1.69e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—AKT2—hypertension	7.68e-07	1.69e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—C3—hypertension	7.68e-07	1.69e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—EGFR—hypertension	7.65e-07	1.68e-05	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PTEN—hypertension	7.65e-07	1.68e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CAV1—hypertension	7.63e-07	1.67e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—APOA1—hypertension	7.61e-07	1.67e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—KDR—hypertension	7.54e-07	1.66e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PDGFB—hypertension	7.48e-07	1.64e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—SERPINE1—hypertension	7.46e-07	1.64e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—RELA—hypertension	7.46e-07	1.64e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PPARG—hypertension	7.45e-07	1.64e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—FGFR1—hypertension	7.44e-07	1.63e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—TH—hypertension	7.38e-07	1.62e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CALM2—hypertension	7.35e-07	1.61e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—POMC—hypertension	7.35e-07	1.61e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HIF1A—hypertension	7.33e-07	1.61e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MTOR—hypertension	7.32e-07	1.61e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—INS—hypertension	7.31e-07	1.6e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—SERPINE1—hypertension	7.3e-07	1.6e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—AGT—hypertension	7.3e-07	1.6e-05	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—EP300—hypertension	7.3e-07	1.6e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—AKT1—hypertension	7.26e-07	1.59e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—hypertension	7.26e-07	1.59e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—FN1—hypertension	7.26e-07	1.59e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PRKCB—hypertension	7.26e-07	1.59e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—F2—hypertension	7.26e-07	1.59e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—FGF2—hypertension	7.23e-07	1.59e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—RHOA—hypertension	7.2e-07	1.58e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—SLC2A4—hypertension	7.18e-07	1.58e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GCG—hypertension	7.18e-07	1.58e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CALM1—hypertension	7.18e-07	1.58e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—APOE—hypertension	7.15e-07	1.57e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—LEP—hypertension	7.15e-07	1.57e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NOS3—hypertension	7.13e-07	1.56e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PIK3R1—hypertension	7.13e-07	1.56e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NOTCH1—hypertension	7.1e-07	1.56e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CAV1—hypertension	7.09e-07	1.56e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—APOA1—hypertension	7.07e-07	1.55e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—FGF2—hypertension	7.07e-07	1.55e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—RHOA—hypertension	7.04e-07	1.55e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CXCL8—hypertension	7.03e-07	1.54e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—KDR—hypertension	7.01e-07	1.54e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PIK3R1—hypertension	6.97e-07	1.53e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NOS3—hypertension	6.97e-07	1.53e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GOT1—hypertension	6.95e-07	1.53e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—AKT1—hypertension	6.79e-07	1.49e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CYP19A1—hypertension	6.75e-07	1.48e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—STK11—hypertension	6.75e-07	1.48e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PRKCB—hypertension	6.74e-07	1.48e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—FN1—hypertension	6.74e-07	1.48e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—F2—hypertension	6.74e-07	1.48e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—RELA—hypertension	6.71e-07	1.47e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—ALB—hypertension	6.7e-07	1.47e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—IL6—hypertension	6.69e-07	1.47e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—POMC—hypertension	6.61e-07	1.45e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NOTCH1—hypertension	6.6e-07	1.45e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MTOR—hypertension	6.58e-07	1.44e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—INS—hypertension	6.58e-07	1.44e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—RELA—hypertension	6.56e-07	1.44e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCL2—hypertension	6.47e-07	1.42e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MTOR—hypertension	6.44e-07	1.41e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PIK3R1—hypertension	6.41e-07	1.41e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—NOS3—hypertension	6.41e-07	1.41e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IGF1—hypertension	6.36e-07	1.4e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MMP9—hypertension	6.36e-07	1.4e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—AKT2—hypertension	6.36e-07	1.4e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CDKN1A—hypertension	6.34e-07	1.39e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hypertension	6.34e-07	1.39e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—EGFR—hypertension	6.33e-07	1.39e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PTEN—hypertension	6.32e-07	1.39e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CXCL8—hypertension	6.32e-07	1.39e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—COMT—hypertension	6.27e-07	1.38e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PPARGC1A—hypertension	6.19e-07	1.36e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GNB3—hypertension	6.19e-07	1.36e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MAPK8—hypertension	6.19e-07	1.36e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CXCL8—hypertension	6.18e-07	1.36e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—AKT1—hypertension	6.17e-07	1.35e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—HMOX1—hypertension	6.16e-07	1.35e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—POMC—hypertension	6.14e-07	1.35e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—INS—hypertension	6.11e-07	1.34e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—AKT1—hypertension	6.11e-07	1.34e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CAT—hypertension	6.08e-07	1.33e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hypertension	6.04e-07	1.33e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SERPINE1—hypertension	6.04e-07	1.33e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—EP300—hypertension	6.03e-07	1.32e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GNAS—hypertension	6.02e-07	1.32e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—IL6—hypertension	6.01e-07	1.32e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCL2—hypertension	6.01e-07	1.32e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—AKT1—hypertension	5.97e-07	1.31e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IGF1—hypertension	5.91e-07	1.3e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—AKT2—hypertension	5.91e-07	1.3e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—APOB—hypertension	5.9e-07	1.29e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—IL6—hypertension	5.88e-07	1.29e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—EGFR—hypertension	5.88e-07	1.29e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—SRC—hypertension	5.86e-07	1.29e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PTGS2—hypertension	5.86e-07	1.29e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—FGF2—hypertension	5.85e-07	1.28e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—RHOA—hypertension	5.83e-07	1.28e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PIK3R1—hypertension	5.77e-07	1.27e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NOS3—hypertension	5.77e-07	1.27e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GSTM1—hypertension	5.74e-07	1.26e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MMP9—hypertension	5.72e-07	1.26e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—VEGFA—hypertension	5.71e-07	1.25e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CDKN1A—hypertension	5.7e-07	1.25e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PTEN—hypertension	5.68e-07	1.25e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—LPL—hypertension	5.63e-07	1.24e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SERPINE1—hypertension	5.61e-07	1.23e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MMP9—hypertension	5.59e-07	1.23e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CDKN1A—hypertension	5.57e-07	1.22e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MAPK8—hypertension	5.56e-07	1.22e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PTEN—hypertension	5.56e-07	1.22e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—AKT1—hypertension	5.55e-07	1.22e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ADCY5—hypertension	5.51e-07	1.21e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GPX1—hypertension	5.5e-07	1.21e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PRKCA—hypertension	5.44e-07	1.19e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CYP1A1—hypertension	5.44e-07	1.19e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MAPK8—hypertension	5.44e-07	1.19e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—FGF2—hypertension	5.43e-07	1.19e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—RELA—hypertension	5.43e-07	1.19e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—AKT1—hypertension	5.42e-07	1.19e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—EP300—hypertension	5.42e-07	1.19e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—RHOA—hypertension	5.41e-07	1.19e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PIK3R1—hypertension	5.36e-07	1.18e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NOS3—hypertension	5.36e-07	1.18e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CD36—hypertension	5.35e-07	1.17e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MTOR—hypertension	5.32e-07	1.17e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—EP300—hypertension	5.3e-07	1.16e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—SRC—hypertension	5.27e-07	1.16e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MYC—hypertension	5.25e-07	1.15e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TGFB1—hypertension	5.24e-07	1.15e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—SRC—hypertension	5.16e-07	1.13e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—EGFR—hypertension	5.14e-07	1.13e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—VEGFA—hypertension	5.13e-07	1.13e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCL8—hypertension	5.12e-07	1.12e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PTEN—hypertension	5.11e-07	1.12e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—MTHFR—hypertension	5.07e-07	1.11e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—RELA—hypertension	5.04e-07	1.11e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—VEGFA—hypertension	5.02e-07	1.1e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PPARA—hypertension	4.98e-07	1.09e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MTOR—hypertension	4.95e-07	1.09e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—AKT1—hypertension	4.94e-07	1.08e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—EP300—hypertension	4.87e-07	1.07e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL6—hypertension	4.86e-07	1.07e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—AGT—hypertension	4.82e-07	1.06e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCL8—hypertension	4.75e-07	1.04e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CALM1—hypertension	4.74e-07	1.04e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MYC—hypertension	4.72e-07	1.04e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—APOE—hypertension	4.72e-07	1.04e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TGFB1—hypertension	4.71e-07	1.03e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CAV1—hypertension	4.68e-07	1.03e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—APOA1—hypertension	4.67e-07	1.02e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MMP9—hypertension	4.63e-07	1.02e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MYC—hypertension	4.62e-07	1.01e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—EGFR—hypertension	4.62e-07	1.01e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CDKN1A—hypertension	4.61e-07	1.01e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TGFB1—hypertension	4.61e-07	1.01e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PTEN—hypertension	4.6e-07	1.01e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—AKT1—hypertension	4.59e-07	1.01e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—EGFR—hypertension	4.52e-07	9.92e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL6—hypertension	4.52e-07	9.92e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MAPK8—hypertension	4.5e-07	9.88e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—AKT1—hypertension	4.49e-07	9.85e-06	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—AKT1—hypertension	4.41e-07	9.68e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—EP300—hypertension	4.39e-07	9.63e-06	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TP53—hypertension	4.32e-07	9.47e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MMP9—hypertension	4.3e-07	9.44e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CDKN1A—hypertension	4.28e-07	9.4e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PTEN—hypertension	4.27e-07	9.38e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SRC—hypertension	4.27e-07	9.36e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MAPK8—hypertension	4.18e-07	9.18e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—AKT1—hypertension	4.17e-07	9.15e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—VEGFA—hypertension	4.15e-07	9.12e-06	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PPARG—hypertension	4.11e-07	9.03e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—EP300—hypertension	4.08e-07	8.95e-06	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—POMC—hypertension	4.06e-07	8.9e-06	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—INS—hypertension	4.03e-07	8.85e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SRC—hypertension	3.96e-07	8.7e-06	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL6—hypertension	3.95e-07	8.67e-06	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TP53—hypertension	3.88e-07	8.52e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—VEGFA—hypertension	3.86e-07	8.47e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MYC—hypertension	3.82e-07	8.39e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TGFB1—hypertension	3.81e-07	8.37e-06	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TP53—hypertension	3.8e-07	8.33e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—EGFR—hypertension	3.74e-07	8.21e-06	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ALB—hypertension	3.7e-07	8.12e-06	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—AKT1—hypertension	3.64e-07	8e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MYC—hypertension	3.55e-07	7.8e-06	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL6—hypertension	3.55e-07	7.79e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TGFB1—hypertension	3.54e-07	7.78e-06	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PIK3R1—hypertension	3.54e-07	7.76e-06	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—NOS3—hypertension	3.54e-07	7.76e-06	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL6—hypertension	3.47e-07	7.62e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—EGFR—hypertension	3.47e-07	7.62e-06	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—AKT1—hypertension	3.28e-07	7.19e-06	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PTGS2—hypertension	3.24e-07	7.1e-06	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—AKT1—hypertension	3.2e-07	7.03e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TP53—hypertension	3.14e-07	6.89e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—AKT1—hypertension	2.95e-07	6.47e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TP53—hypertension	2.92e-07	6.4e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL6—hypertension	2.87e-07	6.31e-06	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PTEN—hypertension	2.82e-07	6.19e-06	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—EP300—hypertension	2.69e-07	5.91e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL6—hypertension	2.67e-07	5.86e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—AKT1—hypertension	2.65e-07	5.82e-06	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—AKT1—hypertension	2.46e-07	5.41e-06	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—AKT1—hypertension	1.63e-07	3.57e-06	CbGpPWpGaD
